FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiroji Uemura

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Physiology

Gene Expression Regulation, Neoplastic

Concepts & Ideas

Neoplasm Staging

Co-author Network

Publications

TOP 3
Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Manabu Kakizoe; Yoshitake Kato; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Early ureteral catheter removal after ureteroscopic lithotripsy using ureteral access sheath.
Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Yoshitake Kato; Takehiko Ogawa; Katsuyuki Tanaka; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Correlation between the operation time using two different power settings of a Ho: YAG laser: laser power doesn't influence lithotripsy time.
Takashi Kawahara; Yoshinobu Kubota; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Hiroki Ito; Junichi Matsuzaki
Changing to a loop-type ureteral stent decreases patients' stent-related symptoms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiroji Uemura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Manabu Kakizoe; Yoshitake Kato; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Early ureteral catheter removal after ureteroscopic lithotripsy using ureteral access sheath.
Urolithiasis 2013;41(1):31-5.
2013: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Yoshitake Kato; Takehiko Ogawa; Katsuyuki Tanaka; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Correlation between the operation time using two different power settings of a Ho: YAG laser: laser power doesn't influence lithotripsy time.
BMC research notes 2013;6():80.
2012: Takashi Kawahara; Yoshinobu Kubota; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Hiroki Ito; Junichi Matsuzaki
Changing to a loop-type ureteral stent decreases patients' stent-related symptoms.
Urological research 2012;40(6):763-7.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Yoshitake Kato; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Ureteroscopy-assisted retrograde nephrostomy (UARN) for an incomplete double ureter.
Urological research 2012;40(6):781-2.
2012: Naohito Kobayashi; Yoshinobu Kubota; Kiyotaka Nagahama; Yoji Nagashima; Koji Okudela; Hiroji Uemura; Ichiro Aoki; Mitsuko Furuya; Hisashi Hirano; Yoshiaki Inayama; Yoko Ino; Yusuke Ito; Hitoshi Ishiguro
Identification of miR-30d as a novel prognostic maker of prostate cancer.
Oncotarget 2012;3(11):1455-71.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Yoshitake Kato; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Amplatz sheath for cystolithotripsy using Ho: YAG laser in female patients.
Urology 2012;80(5):1154-5.
2012: Yoshinobu Kubota; Hiroji Uemura
[Renin-angiotensin system (RAS) as new molecular therapeutic targets in prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(9):1604-12.
2012: Hiroji Uemura; Yoshinobu Kubota
[Cancer and renin-angiotensin system].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(9):1530-5.
2012: Takashi Kawahara; Yoshinobu Kubota; Hanako Ishigaki; Hiroki Ito; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Preoperative stenting for ureteroscopic lithotripsy for a large renal stone.
International journal of urology : official journal of the Japanese Urological Association 2012;19(9):881-5.
2012: Takashi Kawahara; Yoshinobu Kubota; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Hiroki Ito; Junichi Matsuzaki
Stone area and volume are correlated with operative time for cystolithotripsy for bladder calculi using a holmium: yttrium garnet laser.
Scandinavian journal of urology and nephrology 2012;46(4):298-303.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Minoru Yoshida; Junichi Matsuzaki
Ureteroscopy assisted retrograde nephrostomy: a new technique for percutaneous nephrolithotomy (PCNL).
BJU international 2012;110(4):588-90.
2012: Takashi Kawahara; Yoshinobu Kubota; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Hiroki Ito; Junichi Matsuzaki
Ureteroscopy-assisted retrograde nephrostomy for percutaneous nephrolithotomy after urinary diversion.
Case reports in nephrology and urology 2012;2(2):113-7.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Minoru Yoshida; Junichi Matsuzaki
Which is the best method to estimate the actual ureteral length in patients undergoing ureteral stent placement?
International journal of urology : official journal of the Japanese Urological Association 2012;19(7):634-8.
2012: Kanji Endoh; Hisashi Hirano; Hitoshi Ishiguro; Yoshinobu Kubota; Yohei Miyagi; Mayuko Nishi; Ichiro Aoki; Hiroji Uemura; Akihide Ryo
Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
The Prostate 2012;72(6):626-37.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Yoshitake Kato; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Effectiveness of ureteroscopy-assisted retrograde nephrostomy (UARN) for percutaneous nephrolithotomy (PCNL).
PloS one 2012;7(12):e52149.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroshi Misaki; Yasuhide Miyoshi; Kazumi Noguchi; Futoshi Sano; Zenkichi Sekiguchi; Jun-ichi Teranishi; Narihiko Hayashi; Hiroji Uemura
Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel.
PloS one 2012;7(10):e48186.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Yoshitake Kato; Takehiko Ogawa; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Ureteroscopy-Assisted Retrograde Nephrostomy (UARN) after Anatrophic Nephrolithotomy.
Case reports in medicine 2012;2012():164963.
2012: Takashi Kawahara; Yoshinobu Kubota; Hiroki Ito; Takehiko Ogawa; Katsuyuki Tanaka; Hideyuki Terao; Hiroji Uemura; Junichi Matsuzaki
Ureteroscopy-assisted retrograde nephrostomy for lower calyx calculi in horseshoe kidney: two case reports.
Journal of medical case reports 2012;6(1):194.
2011: Takashi Kawahara; Hiroki Ito; Kazuhide Makiyama; Hisashi Oshiro; Zenkichi Sekiguchi; Hiroji Uemura; Yoshinobu Kubota
High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy.
International journal of urology : official journal of the Japanese Urological Association 2011;18(12):851-3.
2011: Hitoshi Ishiguro; Eriko Kagawa; Yoshinobu Kubota; Yoji Nagashima; Shigeo Ohno; Jin-yu Sano; Kazunori Sasaki; Takeshi Sasaki; Ryo Takagawa; Kazunori Akimoto; Ichiro Aoki; Kiyoshi Fujinami; Hiroji Uemura
Coexpression of aPKCλ/ι and IL-6 in prostate cancer tissue correlates with biochemical recurrence.
Cancer science 2011;102(8):1576-81.
2011: Takashi Kawahara; Hiroki Ito; Kimiko Kawahara; Kazuhide Makiyama; Hiroshi Mitsuhashi; Masashi Sakai; Hiroji Uemura; Satoshi Yamaguchi; Yoshinobu Kubota
Spontaneous renal hemorrhage in hemodialysis patients.
Case reports in nephrology and urology 2011;1(1):1-6.
2011: Koji Hoshino; Hitoshi Ishiguro; Jun-ichi Teranishi; Shin-Ichiro Yoshida; Satoshi Umemura; Yoshinobu Kubota; Hiroji Uemura
Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells.
The Prostate 2011;71(9):964-75.
2011: Hiroji Uemura
Role of renin-angiotensin system (RAS) in cancer.
Current cancer drug targets 2011;11(4):393.
2011: Hiroji Uemura; Koji Hoshino; Yoshinobu Kubota
Engagement of renin-angiotensin system in prostate cancer.
Current cancer drug targets 2011;11(4):442-50.
2011: Futoshi Sano; Hideyuki Terao; Takashi Kawahara; Yasuhide Miyoshi; Takeshi Sasaki; Kazumi Noguchi; Yoshinobu Kubota; Hiroji Uemura
Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer.
BJU international 2011;107(9):1404-10.
2010: Takashi Kawahara; Zenkichi Sekiguchi; Kaoru Kita; Kazuhide Makiyama; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
Transurethral bladder tumor resection (TUR-Bt) in a patient with Osler-Rendu-Weber syndrome.
Urology 2010;75(6):1518.
2010: Takashi Kawahara; Hitoshi Ishiguro; Koji Hoshino; Jun-ichi Teranishi; Yasuhide Miyoshi; Yoshinobu Kubota; Hiroji Uemura
Analysis of NSAID-activated gene 1 expression in prostate cancer.
Urologia internationalis 2010;84(2):198-202.
2010: Miki Miyake; Noboru Nakaigawa; Kaoru Kita; Masahiro Yanagisawa; Hideyuki Terao; Futoshi Sano; Takayuki Murakami; Kazuhide Makiyama; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[Chemotherapy with low-dose docetaxel and estramustine phosphate in patient with liver dysfunction due to liver metastases of hormone-refractory prostate cancer : a case report].
Hinyokika kiyo. Acta urologica Japonica 2010;56(1):45-8.
2009: Hitoshi Ishiguro; Kazunori Akimoto; Yoji Nagashima; Yasuyuki Kojima; Takeshi Sasaki; Yukari Ishiguro-Imagawa; Noboru Nakaigawa; Shigeo Ohno; Yoshinobu Kubota; Hiroji Uemura
aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(38):16369-74.
2009: Miki Miyake; Kazuhide Makiyama; Noboru Nakaigawa; Yasuhide Miyoshi; Futoshi Sano; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[Laparoscopic right partial nephrectomy in the presence of Riedel's lobe of the liver].
Hinyokika kiyo. Acta urologica Japonica 2009;55(8):509-11.
2009: Hideyuki Terao; Kazuhide Makiyama; Masahiro Yanagisawa; Miki Miyake; Futoshi Sano; Kaoru Kita; Takayuki Murakami; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota; Yoshiaki Inayama; Yoji Nagashima
[Mixed epithelial and stromal tumor of kidney: a case report].
Hinyokika kiyo. Acta urologica Japonica 2009;55(8):495-8.
2009: Hiroji Uemura; Yoshinobu Kubota
[Role of renin-angiotensin system in prostate cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(8):1228-33.
2009: Hideyuki Terao; Takehiko Ogawa; Masahiro Yanagisawa; Miki Miyake; Futoshi Sano; Kaoru Kita; Takayuki Murakami; Kazuhide Makiyama; Noboru Nakaigawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[A case of adult-onset idiopathic hypogonadotropic hypogonadism presenting with infertility].
Hinyokika kiyo. Acta urologica Japonica 2009;55(7):437-9.
2009: Mitsuru Komeya; Noboru Nakaigawa; Futoshi Sano; Masayo Kagota; Takayuki Murakami; Kazuhide Makiyama; Yasuhide Miyoshi; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoji Nagashima; Yoshinobu Kubota
[A case of upper urinary tract metastases from sigmoid colon cancer].
Hinyokika kiyo. Acta urologica Japonica 2009;55(6):339-43.
2009: Mitsuru Komeya; Futoshi Sano; Masayo Kagota; Takayuki Murakami; Kazuhide Makiyama; Yasuhide Miyoshi; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Hisashi Ooshiro; Yoji Nagashima; Yoshinobu Kubota
[Case of sarcomatoid renal cell carcinoma developed in the chalked kidney (putty kidney)].
Hinyokika kiyo. Acta urologica Japonica 2009;55(5):253-7.
2009: Hiroji Uemura; Koji Hoshino; Takeshi Sasaki; Yasuhide Miyoshi; Hitoshi Ishiguro; Yoshiaki Inayama; Yoshinobu Kubota
Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
BJU international 2009;103(9):1190-4.
2009: Hiroji Uemura; Yoshinobu Kubota
[Application of angiotensin II receptor blocker in prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine 2009;67(4):807-11.
2009: Yumiko Yokomizo; Yasuhide Miyoshi; Noboru Nakaigawa; Kazuhide Makiyama; Takehiko Ogawa; Masahiro Yao; Yoshinobu Kubota; Hiroji Uemura
Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
Urologia internationalis 2009;82(3):280-5.
2009: Ikuma Kato; Yoshiaki Inayama; Shoji Yamanaka; Hisashi Ohshiro; Kiyoshi Gomi; Sumiko Shirai; Ichiro Aoki; Hiroji Uemura; Yasuhide Miyoshi; Yoshinobu Kubota; Masahiro Yao; Yoji Nagashima
Epithelioid angiomyolipoma of the kidney.
Pathology international 2009;59(1):38-43.
2008: Jun-ichi Teranishi; Hitoshi Ishiguro; Koji Hoshino; Kazumi Noguchi; Yoshinobu Kubota; Hiroji Uemura
Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells.
The Prostate 2008;68(15):1666-73.
2008: Tei-ichiro Ueki; Hiroji Uemura; Yoji Nagashima; Shinsuke Ohta; Hitoshi Ishiguro; Yoshinobu Kubota
Antitumour effect of electrochemotherapy with bleomycin on human prostate cancer xenograft.
BJU international 2008;102(10):1467-71.
2008: Ichiro Ogino; Hiroji Uemura; Tomio Inoue; Yoshinobu Kubota; Kazuto Nomura; N Okamoto
Reduction of prostate motion by removal of gas in rectum during radiotherapy.
International journal of radiation oncology, biology, physics 2008;72(2):456-66.
2008: Hiroji Uemura; Hitoshi Ishiguro; Yukari Ishiguro; Kouji Hoshino; Satoru Takahashi; Yoshinobu Kubota
Angiotensin II induces oxidative stress in prostate cancer.
Molecular cancer research : MCR 2008;6(2):250-8.
2008: Hiroji Uemura; Hitoshi Ishiguro; Yoshinobu Kubota
Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.
International journal of urology : official journal of the Japanese Urological Association 2008;15(1):19-26.
2007: Takayuki Murakami; Kazuhide Makiyama; Yasuhide Miyoshi; Yusuke Ito; Kozue Iguchi; Futoshi Sano; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[A case of laparoscopic heminephroureterectomy for ureter cancer in a horseshoe kidney].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 2007;98(6):786-9.
2007: Hitoshi Ishiguro; Yukari Ishiguro; Yoshinobu Kubota; Hiroji Uemura
Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.
The Prostate 2007;67(9):924-32.
2007: Takayuki Murakami; Koji Hoshino; Hisashi Hasumi; Kazuhide Makiyama; Yasuhide Miyoshi; Minoru Yoshida; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[Only metastasis to uterine corpus from superficial bladder cancer that of no original recurrence].
Hinyokika kiyo. Acta urologica Japonica 2007;53(1):75-7.
2006: Kazumi Noguchi; Jun-ichi Teranishi; Hiroji Uemura; Naoya Fujikawa; Kazuo Saito; Tetsuo Murai
Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer: two case reports.
International journal of urology : official journal of the Japanese Urological Association 2006;13(9):1259-61.
2006: Kazumi Noguchi; Kotaro Suzuki; Jun-ichi Teranishi; Keiichi Kondo; Takeshi Kishida; Kazuo Saito; Hiroji Uemura; Yoshinobu Kubota
Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia.
Hinyokika kiyo. Acta urologica Japonica 2006;52(7):527-30.
2006: Hiroji Uemura; Hitoshi Ishiguro; Yoshinobu Kubota
Angiotensin II receptor blocker: possibility of antitumor agent for prostate cancer.
Mini reviews in medicinal chemistry 2006;6(7):835-44.
2006: Hiroji Uemura; Hisashi Hasumi; Hitoshi Ishiguro; Jun-ichi Teranishi; Yasuhide Miyoshi; Yoshinobu Kubota
Renin-angiotensin system is an important factor in hormone refractory prostate cancer.
The Prostate 2006;66(8):822-30.
2006: Kazumi Noguchi; Takuya Yamagishi; Kotaro Suzuki; Keiichi Kondo; Takeshi Kishida; Kazuo Saito; Yuki Sekiguchi; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota; Masaki Kawai; Kazuto Okajima; Kazuki Kobayashi; Masatoshi Moriyama; Yuzo Kinoshita; Kunihisa Mikata; Kazuo Kitami; Mitsunobu Masuda; Ryuichi Saito; Tetsuo Murai; Takeshi Tomoda; Sumio Noguchi; Naoki Sakai; Atsushi Hamano; Sakae Nomura; Kazuhiko Sato
[Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
Hinyokika kiyo. Acta urologica Japonica 2006;52(5):343-8.
2006: Takeshi Sasaki; Akihide Ryo; Hiroji Uemura; Hitoshi Ishiguro; Yoshiaki Inayama; Shoji Yamanaka; Yoshinobu Kubota; Yoji Nagashima; Masaoki Harada; Ichiro Aoki
An immunohistochemical scoring system of prolyl isomerase Pin1 for predicting relapse of prostate carcinoma after radical prostatectomy.
Pathology, research and practice 2006;202(5):357-64.
2006: Kazumi Noguchi; Hiroji Uemura; Jun-ichi Teranishi; Kiyoshi Fujinami; Yasuhide Miyoshi; Noboru Nakaigawa; Kazuo Saito; Yoshinobu Kubota
[Questionnaire on suitableness and acceptableness of cancer notification in aged Japanese prostate cancer patients].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 2006;97(1):48-56.
2006: Susumu Umemoto; Yasuhide Miyoshi; Yumiko Yokomizo; Shinpei Sugiura; Kazuhide Makiyama; Noboru Nakaigawa; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[A case of salvage combination chemotherapy of gemcitabine plus nedaplatin for squamous cell carcinoma of the ureter].
Hinyokika kiyo. Acta urologica Japonica 2006;52(1):35-9.
2005: Masafumi Nakamura; Hisashi Hasumi; Yasuhide Miyoshi; Shinpei Sugiura; Kiyoshi Fujinami; Masahiro Yao; Yoshinobu Kubota; Hiroji Uemura
Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2005;12(12):1050-4.
2005: Hiroji Uemura; Hisashi Hasumi; Takashi Kawahara; Shinpei Sugiura; Yasuhide Miyoshi; Noboru Nakaigawa; Jun-ichi Teranishi; Kazumi Noguchi; Hitoshi Ishiguro; Yoshinobu Kubota
Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.
International journal of clinical oncology 2005;10(6):405-10.
2005: Hiroji Uemura; Hitoshi Ishiguro; Yoji Nagashima; Takeshi Sasaki; Noboru Nakaigawa; Hisashi Hasumi; Shingo Kato; Yoshinobu Kubota
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells.
Molecular cancer therapeutics 2005;4(11):1699-709.
2005: Akihide Ryo; Hiroji Uemura; Hitoshi Ishiguro; Tatsuya Saitoh; Akira Yamaguchi; Kilian Perrem; Yoshinobu Kubota; Kun Ping Lu; Ichiro Aoki
Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7523-31.
2005: Hiroji Uemura; Noboru Nakaigawa; Hitoshi Ishiguro; Yoshinobu Kubota
Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer.
Current cancer drug targets 2005;5(5):307-23.
2005: Hisashi Hasumi; Hitoshi Ishiguro; Masashi Nakamura; Shinpei Sugiura; Yutaka Osada; Yasuhide Miyoshi; Kiyoshi Fujinami; Masahiro Yao; Kenji Hamada; Hisafumi Yamada-Okabe; Yoshinobu Kubota; Hiroji Uemura
Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival.
International journal of cancer. Journal international du cancer 2005;115(6):911-6.
2005: Takako Yamaguchi; Jin Lee; Hiroji Uemura; Takeshi Sasaki; Nobukazu Takahashi; Takashi Oka; Kazuya Shizukuishi; Hisashi Endou; Yoshinobu Kubota; Tomio Inoue
Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.
European journal of nuclear medicine and molecular imaging 2005;32(7):742-8.
2005: Hitoshi Ishiguro; Noboru Nakaigawa; Yasuhide Miyoshi; Kiyoshi Fujinami; Yoshinobu Kubota; Hiroji Uemura
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
The Prostate 2005;64(1):92-100.
2005: Yasuhide Miyoshi; Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugiura; Kazuhide Makiyama; Noboru Nakaigawa; Takeshi Kishida; Takehiko Ogawa; Masahiro Yao; Yoshinobu Kubota
Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients.
International journal of clinical oncology 2005;10(3):182-6.
2005: Masaki Kawai; Hiroji Uemura; Hisashi Hasumi; Yutaka Osada; Junichi Ohta; Yasuhide Miyoshi; Kunihisa Mikata; Hideki Oh-uchi; Shinpei Sugiura; Kiyoshi Fujinami; Yoshinobu Kubota
[Usefulness of extension of disease as a prognostic factor in relapsed prostate cancer patients of stage D].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 2005;96(3):442-7.
2005: Makoto Funahashi; Futoshi Tuchiya; Kazuhide Makiyama; Shinpei Sugiura; Yasuhide Miyoshi; Takeshi Kishida; Takehiko Ogawa; Hiroji Uemura; Masahiro Yao; Yoshinobu Kubota
[Two cases of testicular tumors with high alpha-fetoprotein levels: a case report].
Hinyokika kiyo. Acta urologica Japonica 2005;51(2):133-7.
2005: Hiroji Uemura; Noboru Nakaigawa; Hitoshi Ishiguro; Yoshinobu Kubota
[Novel molecular targeting therapeutics for prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine 2005;63(2):339-44.
2005: Yasuhide Miyoshi; Hiroji Uemura; Yoshinobu Kubota
[Treatment of androgen-independent hormone refractory prostate cancer using docetaxel].
Nihon rinsho. Japanese journal of clinical medicine 2005;63(2):298-302.
2005: Takuya Yamagishi; Hiroji Uemura; Noboru Nakaigawa; Kazumi Noguchi; Yoshinobu Kubota
Angiotensin II blocker decreases serum prostate specific antigen in hormone refractory prostate cancer.
The Journal of urology 2005;173(2):441.
2005: Hideki Ouchi; Hitoshi Ishiguro; Naoya Ikeda; Mayumi Hori; Yoshinobu Kubota; Hiroji Uemura
Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
International journal of urology : official journal of the Japanese Urological Association 2005;12(1):73-80.
2004: Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugiura; Kiyoshi Fujinami; Yasuhide Miyoshi; Masahiro Yao; Yoshinobu Kubota
Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy.
International journal of urology : official journal of the Japanese Urological Association 2004;11(7):494-500.
2004: Jin Lee; Takako Yamaguchi; Aya Abe; Kazuya Shizukuishi; Hiroji Uemura; Etsuko Miyagi; Katsumi Sakata; Tomio Inoue
Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors.
Radiation medicine 2004;22(3):148-54.
2004: Yuzo Yamashita; Kiyoshi Fujinami; Hisashi Hasumi; Takeshi Kishida; Hiroji Uemura; Masahiro Yao; Sumio Noguchi; Yoshinobu Kubota
[A case of primary choriocarcinoma of the bladder].
Hinyokika kiyo. Acta urologica Japonica 2004;50(4):261-4.
2003: Hiroji Uemura; Hitoshi Ishiguro; Noboru Nakaigawa; Yoji Nagashima; Yasuhide Miyoshi; Kiyoshi Fujinami; Akihiro Sakaguchi; Yoshinobu Kubota
Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.
Molecular cancer therapeutics 2003;2(11):1139-47.
2003: Yasuhide Miyoshi; Hitoshi Ishiguro; Hiroji Uemura; Kiyoshi Fujinami; Hiroshi Miyamoto; Yoshiko Miyoshi; Hitoshi Kitamura; Yoshinobu Kubota
Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
The Prostate 2003;56(4):280-6.
2003: Takehiro Tajiri; Kazumi Noguchi; Takeshi Kishida; Hiroji Uemura; Kazuo Saito; Masahiro Yao; Mitsumasa Takeda; Yoshinobu Kubota
[Investigation of 14 renal cell carcinoma cases with tumor thrombus in the inferior vena cava].
Hinyokika kiyo. Acta urologica Japonica 2003;49(8):457-61.
2003: Hitoshi Ishiguro; Hiroji Uemura; Kiyoshi Fujinami; Naoya Ikeda; Shinsuke Ohta; Yoshinobu Kubota
55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor.
International journal of cancer. Journal international du cancer 2003;105(1):26-32.
2002: Hiroji Uemura; Naoya Ikeda; Noboru Nakaigawa; Hideki Ouchi; Hitoshi Ishiguro; Yoshinobu Kubota
[A novel molecular target therapeutics for refractory prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 11():272-7.
2002: Hisashi Hasumi; Takeshi Kishida; Jun-ichi Teranishi; Noboru Nakaigawa; Kiyoshi Fujinami; Ichirou Ikeda; Hiroji Uemura; Masahiro Yao; Mitsumasa Takeda; Sumio Noguchi; Yoshinobu Kubota
[High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer].
Hinyokika kiyo. Acta urologica Japonica 2002;48(8):469-73.
2002: Kiyoshi Fujinami; Hiroji Uemura; Hitoshi Ishiguro; Yoshinobu Kubota
Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
International journal of molecular medicine 2002;10(2):173-6.
2002: Kunihisa Mikata; Hiroji Uemura; Hideki Ohuchi; Shinsuke Ohta; Yoji Nagashima; Yoshinobu Kubota
Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: gene transfer by electroporation.
Molecular cancer therapeutics 2002;1(4):247-52.
2001: Y Miyoshi; Hiroji Uemura; K Kitami; Yoshiaki Satomi; Yoshinobu Kubota; Masahiko Hosaka
Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy.
BJU international 2001;88(9):982-3.
2001: Junichi Ohta; Yoshiko Miyoshi; Hiroji Uemura; Kiyoshi Fujinami; Kunihisa Mikata; Masahiko Hosaka; Y Tokita; Yoshinobu Kubota
Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2463-7.
2001: Kunihisa Mikata; Hiroji Uemura; Kiyoshi Fujinami; Hideki Ohuchi; Yoshiko Miyoshi; Junichi Ohta; Yutaka Osada; S Jinza; Yoshinobu Kubota; Masahiko Hosaka; I Nakatani; S Takebayashi
[Diagnosis of prostate capsular invasion by pelvic magnetic resonance imaging and serum level of prostate specific antigen].
Hinyokika kiyo. Acta urologica Japonica 2001;47(6):385-8.
2001: Yoshiko Miyoshi; Hiroji Uemura; Kunihisa Mikata; Hideki Ohuchi; S Jinza; Masahiro Yao; Mitsumasa Takeda; Michiaki Masuda; Sumio Noguchi; Kazumi Noguchi; Yoshinobu Kubota; Masahiko Hosaka
[Clinical outcome and analysis of radical prostatectomy in clinical stage B and C prostate cancer].
Hinyokika kiyo. Acta urologica Japonica 2001;47(3):163-8.
2001: Kazumi Noguchi; Hiroji Uemura; M Harada; Takeshi Miura; M Moriyama; H Fukuoka; K Kitami; Masahiko Hosaka
Inhibition of PSA flare in prostate cancer patients by administration of flutamide for 2 weeks before initiation of treatment with slow-releasing LH-RH agonist.
International journal of clinical oncology 2001;6(1):29-33.
2001: K Kondo; Masahiro Yao; K Kobayashi; S Ota; M Yoshida; S Kaneko; M Baba; N Sakai; T Kishida; S Kawakami; Hiroji Uemura; Yoji Nagashima; Y Nakatani; M Hosaka
PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines.
International journal of cancer. Journal international du cancer 2001;91(2):219-24.
2000: Hideki Ohuchi; Kunihisa Mikata; Yoshiko Miyoshi; Junichi Ohta; Yutaka Osada; Hiroji Uemura; Masahiro Yao; Mitsumasa Takeda; Sumio Noguchi; Yoshinobu Kubota; Masahiko Hosaka; S Jinza; T Asakura; T Ebato
[Study of free to total prostate specific antigen ratio in the detection of patients with prostate cancer].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 2000;91(12):695-9.
2000: Kazumi Noguchi; Hiroji Uemura; Mitsumasa Takeda; Y Sekiguchi; K Ogawa; Masahiko Hosaka
[Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].
Hinyokika kiyo. Acta urologica Japonica 2000;46(9):605-7.
2000: Hiroji Uemura; F Kanda; Naoya Ikeda; Yoshinobu Kubota
[Telomerase activity in prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine 2000;58 Suppl():427-9.
2000: Yoshiko Miyoshi; Hiroji Uemura; Kiyoshi Fujinami; Kunihisa Mikata; M Harada; Hitoshi Kitamura; Y Koizumi; Yoshinobu Kubota
Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients.
The Prostate 2000;43(3):225-32.
1998: Sumio Noguchi; K Takase; Yoshinobu Kubota; Hiroji Uemura; K Saitoh; Michiaki Masuda; Masahiro Yao; Masahiko Hosaka
[Analysis of the prognostic factor in the patients with locally invasive bladder cancer who underwent total cystectomy].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 1998;89(10):816-22.
1998: Y Lin; Hiroji Uemura; Kiyoshi Fujinami; M Hosaka; Y Iwasaki; Hitoshi Kitamura; M Harada; Yoshinobu Kubota
Detection of telomerase activity in prostate needle-biopsy samples.
The Prostate 1998;36(2):121-8.
1998: Hiroji Uemura; Y Lin; Yoshinobu Kubota
[Telomerase activity in association with the pathological differentiation of prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine 1998;56(5):1287-91.
1998: Kiyoshi Fujinami; I Kondo; Takeshi Miura; M Harada; Hiroji Uemura; Masahiko Hosaka; C Kawasaki
[Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer].
Hinyokika kiyo. Acta urologica Japonica 1998;44(4):259-63.
1997: Y Lin; Hiroji Uemura; Kiyoshi Fujinami; Masahiko Hosaka; M Harada; Yoshinobu Kubota
Telomerase activity in primary prostate cancer.
The Journal of urology 1997;157(3):1161-5.
1997: I Kondo; Takeshi Miura; Kiyoshi Fujinami; Yoshiaki Satomi; T Ida; Eiichi Ishizuka; Hiroji Uemura; Sumio Noguchi; Y Kubota; Masahiko Hosaka; M Harada
[Comparative histological analysis of needle biopsy specimens, prostatectomized specimens and metastatic lymph nodes in prostatic adenocarcinoma--on the basis of the WHO histological classification].
Hinyokika kiyo. Acta urologica Japonica 1997;43(2):97-101.
1996: Y Lin; H Miyamoto; Kiyoshi Fujinami; Hiroji Uemura; Masahiko Hosaka; Y Iwasaki; Yoshinobu Kubota
Telomerase activity in human bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(6):929-32.
1995: Yoshinobu Kubota; Kiyoshi Fujinami; Hiroji Uemura; Y Dobashi; H Miyamoto; Y Iwasaki; H Kitamura; Taro Shuin
Retinoblastoma gene mutations in primary human prostate cancer.
The Prostate 1995;27(6):314-20.
1995: Yoshinobu Kubota; Taro Shuin; Hiroji Uemura; Kiyoshi Fujinami; H Miyamoto; S Torigoe; Y Dobashi; H Kitamura; Y Iwasaki; Kathleen D Danenberg
Tumor suppressor gene p53 mutations in human prostate cancer.
The Prostate 1995;27(1):18-24.
1994: Y Dobashi; Taro Shuin; H Tsuruga; Hiroji Uemura; S Torigoe; Yoshinobu Kubota
DNA polymerase beta gene mutation in human prostate cancer.
Cancer research 1994;54(11):2827-9.